SAO PAULO, Oct 7 (Reuters) - Canada's Knight Terapeutics GUD.TO and Brazilian pharmaceuticals company Eurofarma are interested in acquiring control of Biotoscana Investments SA GBIO33.SA, financial blog Brazil Journal reported on Monday, citing unnamed sources.
Biotoscana's largest shareholders, private equity firm Advent International and specialist investment firm EW Healthcare Partners, are in talks with the groups, Brazil Journal said.
Shares in Biotoscana rose 15% in early trade to 9.25 reais ($2.28) after the report.
Advent, EW Healthcare, Eurofarma, Knight Terapeutics and Biotoscana did not reply immediately to requests for comment.
($1 = 4.0648 reais)
(Reporting by Tatiana Bautzer Editing by David Goodman)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.